JDOC – JPMorgan Healthcare Leaders ETF
JPMorgan Healthcare Leaders ETF (JDOC) is a Health ETF, issued by JPMorgan, $8.9M in assets, 0.65% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.4%, 1 year +12.8%.
Focuses on leading pharmaceutical, biotechnology, healthcare services, technology, and life sciences companies with underappreciated growth potential.
Top holdings
- LLY – Eli Lilly and Company, 7.2%
- JNJ – Johnson & Johnson, 6.6%
- ABBV – AbbVie Inc, 5.2%
- MRK – Merck & Company Inc, 5.1%
- AZN – AstraZeneca PLC, 4.8%
- 0QIU – Novo Nordisk A/S Class B, 3.8%
- DHR – Danaher Corporation, 3.4%
- UNH – UnitedHealth Group Incorporated, 3.1%
- MDT – Medtronic PLC, 2.9%
- ROG – Roche Holding AG, 2.8%
- CVS – CVS Health Corp, 2.6%
- BMY – Bristol-Myers Squibb Company, 2.4%
- ARGX – Argen-X, 2.2%
- MCK – McKesson Corporation, 2.1%
- BSX – Boston Scientific Corp, 2.1%
- REGN – Regeneron Pharmaceuticals Inc, 2.1%
- LONN – Lonza Group AG, 2.0%
- EL – EssilorLuxottica S. A., 2.0%
- EW – Edwards Lifesciences Corp, 1.9%
- UCB – UCB SA, 1.9%
- 7741 – Hoya Cor, 1.8%
- TMO – Thermo Fisher Scientific Inc, 1.8%
- VRTX – Vertex Pharmaceuticals Inc, 1.7%
- SYK – Stryker Corporation, 1.7%
- CAH – Cardinal Health Inc, 1.5%